Clément Marcelin

Dr. Clément Marcelin

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
CMClément Marcelin
Clément Marcelin
JIJ. Izaaryene
J. Izaaryene
MCM. Castelli
M. Castelli
PBP.A. Barral
P.A. Barral
AJA. Jacquier
A. Jacquier
JBJ.M. Bartoli
J.M. Bartoli

Verified
Journal Article
Open access
PDF file
RLRomaric Loffroy
Romaric Loffroy
KGKévin GUILLEN
Kévin GUILLEN
ESetienne salet
etienne salet
CMClément Marcelin
Clément Marcelin
PCPierre-Olivier Comby
Pierre-Olivier Comby
FPFrançois Petitpierre
François Petitpierre
Our goal was to evaluate the feasibility, safety, and short-term outcomes of prostate artery embolization (PAE) with N-butyl cyanoacrylate (NBCA) glue as the only embolic agent in patients with benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTSs). A two-center retrospective study of 50 patients (mean age, 67.6 ± 7.4 years; range, 54–85 years) treated with NBCA between 2017 and 2020 was conducted. PAE was performed using a mixture of Glubran 2 glue and Lipiodol in a 1:8 ratio, under local anesthesia, on an outpatient basis, after cone-beam computed tomography vascular mapping. Mean total injected NBCA/Lipiodol volume was 0.9 ± 0.3 mL, total injection time was 21.9 ± 7.8 s, and total radiation dose was 18,458 ± 16,397 mGy·cm. Statistically significant improvements over time occurred for the International Prostate Symptoms Score (9.9 ± 6.8 versus 20.5 ± 6.7, p = 0.0001), quality-of-life score (2.2 ± 1.5 versus 4.9 ± 1.0, p = 0.0001), prostate-specific antigen level (4.6 ± 3.0 versus 6.4 ± 3.7, p = 0.0001), and prostate volume (77.3 ± 30.5 versus 98.3 ± 40.2, p = 0.0001) at a median of 3 months versus baseline. Minor adverse events developed in 11/50 (22%) patients, but no major complications occurred. The International Index of Erectile Function did not change significantly. PAE with NBCA is feasible, safe, fast, and effective for patients with BPH-related LUTSs. Prospective comparative studies with longer follow-ups are warranted.

27 September 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
CMClément Marcelin
Clément Marcelin
YBYann LE BRAS
Yann LE BRAS
IAIsabelle Molina Andreo
Isabelle Molina Andreo
EJEva Jambon
Eva Jambon
NGNicolas Grenier
Nicolas Grenier
Pelvic venous pathologies in females are responsible for chronic symptoms grouped under the term pelvic congestion syndrome, which includes chronic pelvic pain, perineal heaviness, urgency, and postcoital pain, along with vulvar, perineal, and lower limb varicose veins. These conditions are also associated with ovarian and pelvic venous reflux and venous obstruction. This review aimed to explore the clinical and imaging modalities for diagnosing pelvic congestion syndrome, pelvic venous pathologies, their therapeutic management, and their outcomes.

1 July 2018 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
CMClément Marcelin
Clément Marcelin
JSJérome Soussan
Jérome Soussan
FDFlorian Desmots
Florian Desmots
JGJean-Yves Gaubert
Jean-Yves Gaubert
VVVincent Vidal
Vincent Vidal
JIJean Izaaryene
Jean Izaaryene

1 April 2023 in European Radiology
Verified
Journal Article
Closed access
PDF file
GCGrégoire Cazalas
Grégoire Cazalas
CKClément Klein
Clément Klein
GPGilles Piana
Gilles Piana
EKEric De Kerviler
Eric De Kerviler
AGAfshin Gangi
Afshin Gangi
CMClément Marcelin
Clément Marcelin

1 June 2017 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
CMClément Marcelin
Clément Marcelin
YBY. Le Bras
Y. Le Bras
FPF. Petitpierre
F. Petitpierre
DMD. Midy
D. Midy
EDE. Ducasse
E. Ducasse
Francois CornelisFrancois Cornelis
Francois Cornelis